Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Inovio Pharmaceuticals Inc (NASDAQ:INO)

5.69
Delayed Data
As of Jan 23
 +1.05 / +22.63%
Today’s Change
4.09
Today|||52-Week Range
9.86
+37.77%
Year-to-Date
3 Stocks Under $10 That Surged Today
Jan 23 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close4.64
Today’s open4.74
Day’s range4.74 - 5.88
Volume7,120,621
Average volume (3 months)1,304,234
Market cap$419.0M
Data as of 4:15pm ET, 01/23/2018

Growth & Valuation

Earnings growth (last year)-129.55%
Earnings growth (this year)--
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-12.83%
P/E ratioNM
Price/Sales14.37
Price/Book2.79

Competitors

 Today’s
change
Today’s
% change
PETQPetIQ Inc-0.38-1.48%
GTHXG1 Therapeutics Inc-0.67-2.64%
ABEOAbeona Therapeutics ...+0.55+3.70%
SCMPSucampo Pharmaceutic...+0.05+0.28%
Data as of 4:00pm ET, 01/23/2018

Financials

Next reporting dateMarch 15, 2018
EPS forecast (this quarter)-$0.30
Annual revenue (last year)$35.4M
Annual profit (last year)-$73.7M
Net profit margin-208.49%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
J. Joseph Kim
Chief Operating Officer
Niranjan Y. Sardesai
Corporate headquarters
Plymouth Meeting, Pennsylvania

Forecasts